1. IL-2 phosphorylates STAT5 to drive IFN-γ production and activation of human dendritic cells.
- Author
-
Herr F, Lemoine R, Gouilleux F, Meley D, Kazma I, Heraud A, Velge-Roussel F, Baron C, and Lebranchu Y
- Subjects
- Antibodies pharmacology, Dendritic Cells cytology, Female, Humans, Interleukin-2 Receptor alpha Subunit antagonists & inhibitors, Interleukin-2 Receptor alpha Subunit immunology, Lipopolysaccharides pharmacology, Male, Monocytes cytology, Monocytes immunology, Phosphorylation drug effects, Phosphorylation immunology, Dendritic Cells immunology, Interferon-gamma immunology, Interleukin-2 immunology, STAT5 Transcription Factor immunology
- Abstract
Human dendritic cells (hDCs) produce IL-2 and express IL-2R α-chain (CD25), but the role of IL-2 in DC functions is not well defined. A recent study suggested that the main function of CD25 on hDCs was to transpresent IL-2 to activate T lymphocytes. Our results demonstrate the expression of the three chains of the IL-2R on hDCs and that IL-2 induces STAT5 phosphorylation. Interestingly, use of inhibitors of p-STAT5 revealed that IL-2 increases LPS-induced IFN-γ through STAT5 phosphorylation. Finally, we report that IL-2 increases the ability of hDCs to activate helpless CD8(+) T cells, most likely because of IL-2-triggered IFN-γ synthesis, as we previously described. For the first time, to our knowledge, we disclose that IL-2 induces monocyte-derived hDC's functional maturation and activation through IL-2R binding. Interestingly, our study suggests a direct effect of anti-CD25 mAbs on hDCs that may contribute to their clinical efficacy., (Copyright © 2014 by The American Association of Immunologists, Inc.)
- Published
- 2014
- Full Text
- View/download PDF